Published in Neurology on April 29, 2008
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol (2009) 4.93
Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet (2008) 3.08
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging (2010) 1.56
The "eye of the tiger" sign in pure akinesia with gait freezing. Neurol Sci (2011) 1.51
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol (2013) 1.20
Neurodegeneration with brain iron accumulation: an overview. Iran J Child Neurol (2014) 1.18
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Mol Genet Metab (2011) 1.13
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica (2011) 1.10
The relationship between hematoma iron content and perihematoma edema: an MRI study. Cerebrovasc Dis (2009) 1.09
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front Pharmacol (2014) 1.09
Hallervorden-Spatz disease. Adv Biomed Res (2014) 1.07
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain (2008) 1.06
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration. Neurobiol Dis (2012) 0.99
Acquired hepatocerebral degeneration. J Neurol (2009) 0.98
Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration. J Magn Reson Imaging (2009) 0.98
MRI findings in neuroferritinopathy. Neurol Res Int (2011) 0.97
Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol (2015) 0.96
The genetics of dystonias. Adv Genet (2012) 0.96
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol (2013) 0.95
Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism. Neurobiol Dis (2015) 0.94
Eye-of-the-Tiger sign is not Pathognomonic of Pantothenate Kinase-Associated Neurodegeneration in Adult Cases. Brain Behav (2011) 0.93
Abnormal iron homeostasis and neurodegeneration. Front Aging Neurosci (2013) 0.93
Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci (2010) 0.92
Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes. J Mov Disord (2015) 0.90
Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J Neural Transm (Vienna) (2012) 0.88
The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician. J Neurol Neurosurg Psychiatry (2012) 0.86
A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits. Neurobiol Dis (2014) 0.84
Neuroferritinopathy: a new inborn error of iron metabolism. Neurogenetics (2012) 0.84
Ferritin overexpression in Drosophila glia leads to iron deposition in the optic lobes and late-onset behavioral defects. Neurobiol Dis (2011) 0.83
Diagnosis of dystonic syndromes--a new eight-question approach. Nat Rev Neurol (2012) 0.83
Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases. Rev Bras Hematol Hemoter (2011) 0.82
GRE T2∗-weighted MRI: principles and clinical applications. Biomed Res Int (2014) 0.81
Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: its possible association with iron accumulation as evidenced by the t2(*) map. Korean J Radiol (2012) 0.81
A novel ferritin light chain mutation in neuroferritinopathy with an atypical presentation. J Neurol Sci (2014) 0.80
Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate. AJNR Am J Neuroradiol (2012) 0.78
Novel compound heterozygous mutations in the pantothenate kinase 2 gene in a korean patient with atypical pantothenate kinase associated neurodegeneration. J Mov Disord (2009) 0.77
Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity. J Neurol (2015) 0.77
Brain iron deposits and lifespan cognitive ability. Age (Dordr) (2015) 0.77
Cortical pencil lining in neuroferritinopathy: a diagnostic clue. Neurology (2015) 0.77
The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction. Tremor Other Hyperkinet Mov (N Y) (2013) 0.76
Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature. Tremor Other Hyperkinet Mov (N Y) (2012) 0.76
Nigropallidal iron accumulation in pantothenate kinase-associated neurodegeneration demonstrated by susceptibility-weighted imaging. J Neurol (2009) 0.76
Transcranial sonography in pantothenate kinase-associated neurodegeneration. J Neurol (2011) 0.76
Mucopolysaccharidosis type IIIB (MPS IIIB) masquerading as a behavioural disorder. BMJ Case Rep (2013) 0.76
Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging. Mol Neurobiol (2016) 0.76
Adductor laryngeal breathing dystonia in NBIA treated with botulinum toxin-A. Ann Indian Acad Neurol (2013) 0.75
Magnetic resonance imaging markers for early diagnosis of Parkinson's disease. Neural Regen Res (2012) 0.75
A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN). Oman Med J (2017) 0.75
Contributions to magnetic susceptibility of brain tissue. NMR Biomed (2016) 0.75
Magnetic resonance imaging in pantothenate kinase-2-associated neurodegeneration. J Pediatr Neurosci (2012) 0.75
Late-onset neurodegeneration with brain iron accumulation with diffusion tensor magnetic resonance imaging. Case Rep Neurol (2012) 0.75
Enhanced susceptibility-weighted angiography (ESWAN) of cerebral arteries and veins at 1.5 Tesla. Br J Radiol (2014) 0.75
Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
Clinical and molecular research of neuroacanthocytosis. Neural Regen Res (2013) 0.75
Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration. Mol Neurobiol (2016) 0.75
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med (2003) 6.47
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology (1999) 2.58
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A (1995) 2.01
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain (2006) 1.48
Late onset diabetes mellitus in patients with hereditary aceruloplasminemia. Intern Med (1996) 1.47
The "eye-of-the-tiger" sign is not pathognomonic of the PANK2 mutation. Arch Neurol (2006) 1.28
Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients. Magn Reson Med (2007) 1.27
The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging (1997) 1.10
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol (2002) 1.04
Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl (2006) 1.03
Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin Pediatr Neurol (2006) 0.96
The eye of the tiger sign in cortical-basal ganglionic degeneration. Mov Disord (1999) 0.96
MR imaging of cerebral cortical involvement in aceruloplasminemia. AJNR Am J Neuroradiol (2005) 0.94
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood (2002) 0.93
Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet (1996) 0.91
T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major. Br J Radiol (2001) 0.90
A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J Exp Med (2000) 0.90
Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures. Mov Disord (2006) 0.89
A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry (2002) 0.87
Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis. J Hepatol (2005) 0.83
Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med (2003) 0.83
Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord (1997) 0.83
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 18.22
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
A comparative survey of the results of analyses of blood serum in clinical chemistry laboratories in the United Kingdom. J Clin Pathol (1973) 3.44
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet (2008) 3.08
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet (2002) 2.67
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Inherited mitochondrial optic neuropathies. J Med Genet (2008) 2.50
Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet (1997) 2.45
Leber hereditary optic neuropathy. J Med Genet (2002) 2.33
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet (2001) 2.31
Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol (2011) 2.30
The pedigree rate of sequence divergence in the human mitochondrial genome: there is a difference between phylogenetic and pedigree rates. Am J Hum Genet (2003) 2.23
Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature (1990) 2.20
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet (2006) 2.05
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A (1995) 2.01
Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol (2003) 1.92
Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am J Hum Genet (2000) 1.89
Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology (2006) 1.87
Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78
Repeated embolism and multiple aneurysms: central nervous system manifestations of cardiac myxoma. Eur J Neurol (2008) 1.72
The phenotype of limb-girdle muscular dystrophy type 2I. Neurology (2003) 1.70
Infants of depressed mothers show "depressed" behavior even with nondepressed adults. Child Dev (1988) 1.65
Prolactin and growth hormone in patients with pituitary adenomas: a correlative study of hormone in tumor and plasma by immunoperoxidase technique and radioimmunoassay. J Clin Endocrinol Metab (1974) 1.60
Iron accumulation in the liver of male patients with Wilson's disease. Am J Gastroenterol (2001) 1.55
Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. Blood (1998) 1.55
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet (1997) 1.53
Analysis of European mtDNAs for recombination. Am J Hum Genet (2000) 1.51
Chemical heterogeneity in cerebellar Purkinje cells: existence and coexistence of glutamic acid decarboxylase-like and motilin-like immunoreactivities. Proc Natl Acad Sci U S A (1981) 1.50
Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology (2004) 1.47
Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43
Arsenic and Ayurveda. Leuk Lymphoma (1993) 1.43
Retracted Dominant-negative effects of a novel mutation in the filamin myopathy. Neurology (2010) 1.42
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Addison's disease in the acquired immunodeficiency syndrome. Med J Aust (1993) 1.39
Prevalence of bisexual behaviour among bridge population of men who have sex with men in China: a meta-analysis of observational studies. Sex Transm Infect (2011) 1.39
Fibrillary astrocytes proliferate in response to brain injury: a study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine. Dev Biol (1979) 1.37
Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology (1987) 1.37
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36
Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology (2009) 1.35
Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology (2006) 1.35
Transmission of tuberculosis in the metropolitan area of Zurich: a 3 year survey based on DNA fingerprinting. Eur Respir J (1998) 1.34
The inheritance of pathogenic mitochondrial DNA mutations. Biochim Biophys Acta (2009) 1.31
In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors (1993) 1.28
Vasopressin and neurophysin: high concentrations in monkey hypophyseal portal blood. Science (1973) 1.25
Age-related decline in mitochondrial DNA copy number in isolated human pancreatic islets. Diabetologia (2008) 1.19
Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry (1997) 1.18
Intra-articular morphine and/or bupivacaine in the management of pain after total knee arthroplasty. J Arthroplasty (1997) 1.17
Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye (Lond) (2011) 1.17
Nucleotide sequence of the cDNA encoding the precursor for mitochondrial serine:pyruvate aminotransferase of rat liver. Eur J Biochem (1987) 1.17
Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspects. Semin Thromb Hemost (1999) 1.16
Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology (1983) 1.15
Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord (2004) 1.15
The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull (1981) 1.11
Immunohistochemical localization of neurotensin in endocrine cells of the gut. Cell Tissue Res (1977) 1.09
Mitochondrial DNA copy number threshold in mtDNA depletion myopathy. Neurology (2005) 1.09
An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy. Am J Hum Genet (1999) 1.08
POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Neurology (2006) 1.08
Reversible cytotoxic cerebral edema in cerebral fat embolism. AJNR Am J Neuroradiol (2006) 1.08
MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol (2007) 1.08
Distribution of infectious pancreatic necrosis virus (IPNV) in wild marine fish from Scottish waters with respect to clinically infected aquaculture sites producing Atlantic salmon, Salmo salar L. J Fish Dis (2008) 1.08
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism. Neurology (2005) 1.08
Tuberculosis in captive seals: bacteriological studies on an isolate belonging to the Mycobacterium tuberculosis complex. Res Vet Sci (1990) 1.07
Brain grafts reverse hypogonadism of gonadotropin releasing hormone deficiency. Nature (1982) 1.07
Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy (2007) 1.07
Magnocellular neurosecretory system. Annu Rev Neurosci (1983) 1.06
The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis. J Clin Immunol (1987) 1.06
Mitochondrial DNA deletion in "identical" twin brothers. J Med Genet (2004) 1.06
Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy. Brain (2013) 1.03
Serial MRI in a case of familial hemiplegic migraine. Neuroradiology (2003) 1.03
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration. J Inherit Metab Dis (2007) 1.03
Spontaneous lesions in cynomolgus monkeys used in toxicity studies. Jikken Dobutsu (1992) 1.03
Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology (2005) 1.02
The influence of postoperative coronal alignment on revision surgery in total knee arthroplasty. Int Orthop (2007) 1.02
Physiologic investigation of posterior pituitary binding proteins neurophysin I and neurophysin II. Metabolism (1971) 1.02
Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children. J Med Genet (2009) 1.02
Motilin in the Purkinje cell of the cerebellum. Nature (1982) 1.02
Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology (2007) 1.02
RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. Neurology (2011) 1.01
The antitussive effect of dextromethorphan in relation to CYP2D6 activity. Br J Clin Pharmacol (1999) 1.01
Primary open angle glaucoma is associated with a specific p53 gene haplotype. J Med Genet (2004) 1.01
Studies on murine IgE with monoclonal antibodies. I. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determinations of serum IgE levels and for anaphylactic reactions. Int Arch Allergy Appl Immunol (1988) 1.00
Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology (2005) 1.00
Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences. J Clin Microbiol (1994) 1.00
Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child (2008) 0.99
Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin. Int J Tuberc Lung Dis (2004) 0.98
Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia. Neurology (1982) 0.98
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain (2010) 0.98
Episodic ataxia and hemiplegia caused by the 8993T->C mitochondrial DNA mutation. J Med Genet (2007) 0.98
Is selection required for the accumulation of somatic mitochondrial DNA mutations in post-mitotic cells? Neuromuscul Disord (2006) 0.98
Infectious salmon anaemia virus in wild fish from Scotland. Dis Aquat Organ (2001) 0.98
Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc Natl Acad Sci U S A (1981) 0.97
PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. Hum Reprod Update (2012) 0.97